# Effect of Intramyocardial Injection of Mesenchymal Precursor Cells on Heart Function in People Receiving an LVAD

> **NCT00927784** · PHASE2 · TERMINATED · sponsor: **Icahn School of Medicine at Mount Sinai** · enrollment: 10 (actual)

## Conditions studied

- Heart Failure

## Interventions

- **BIOLOGICAL:** Mesenchymal Precursor cells (RevascorTM)
- **DRUG:** Cryoprotective media alone

## Key facts

- **NCT ID:** NCT00927784
- **Lead sponsor:** Icahn School of Medicine at Mount Sinai
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-08
- **Primary completion:** 2010-05
- **Final completion:** 2011-02
- **Target enrollment:** 10 (ACTUAL)
- **Why stopped:** The enrollment has been terminated by the NHLBI for administrative reasons.
- **Last updated:** 2019-03-05

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00927784

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00927784, "Effect of Intramyocardial Injection of Mesenchymal Precursor Cells on Heart Function in People Receiving an LVAD". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00927784. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*